Evidence map›Paper›PMID 40807263›Full record

ArticleMolecules (Basel, Switzerland)2025

Synthesis, Characterization, HSA/DNA Binding, and Cytotoxic Activity of [RuCl

Stefan Perendija, Dušan Dimić, Thomas Eichhorn, Aleksandra Rakić, Luciano Saso, Đura Nakarada, Dragoslava Đikić, Teodora Dragojević, Jasmina Dimitrić Marković, Goran N Kaluđerović

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stefan PerendijaFaculty of Physical Chemistry, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0009-0000-4089-0042
Dušan DimićFaculty of Physical Chemistry, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-8127-5396
Thomas EichhornDepartment of Engineering and Natural Sciences, University of Applied Sciences Merseburg, D-06217 Merseburg, Germany.ORCID 0000-0002-6302-1357
Aleksandra RakićFaculty of Physical Chemistry, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-1489-6373
Luciano SasoDepartment of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-4530-8706
Đura NakaradaFaculty of Physical Chemistry, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-0154-6430
Dragoslava ĐikićInstitute for Medical Research, University of Belgrade, 11000 Belgrade, Serbia.
Teodora DragojevićInstitute for Medical Research, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-9015-8351
Jasmina Dimitrić MarkovićFaculty of Physical Chemistry, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-4796-6251
Goran N KaluđerovićDepartment of Engineering and Natural Sciences, University of Applied Sciences Merseburg, D-06217 Merseburg, Germany.ORCID 0000-0001-5168-1000

Funding

German Academic Exchange Service 57656312Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-137/2025-03/200146 and 451-03-136/2025-03/200146
6 · The paper itself

Abstract

A novel ruthenium(II) complex, [RuCl

Indexed as

Antineoplastic AgentsCoordination ComplexesDNARutheniumSerum Albumin, HumanAnimalsAntioxidantsCattleCell Line, TumorCymenesHumansMolecular Docking SimulationThermodynamicsAntineoplastic AgentsAntioxidantscalf thymus DNACoordination ComplexesCymenesDNARutheniumSerum Albumin, HumanDFTDNAEPRHSAin vitro activitymolecular dockingRu(II) complex

Identifiers

PMID40807263
PMCPMC12348660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.